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Inhibition of T helper 2 chemokine 
production by narrowband ultraviolet B 
in cultured keratinocytes
Narrowband ultravio-
let B (UVB) has recent-
ly been used for the 
treatment of various 
skin disorders. Hino 
et al. investigated its 
effects on produc-
tion of cytokines and 
chemokines by kerati-
nocytes. Human epi-
dermal keratinocytes were irradiated with narrowband UVB 
or broadband UVB. The two UVB sources were compared on 
the basis of their minimal erythemal doses and therapeutically 
used doses. Characteristically, narrowband UVB reduced the 
production of Th2 chemokines without excess production of 
proinflammatory cytokines, suggesting its therapeutic effec-
tiveness in Th2-mediated skin disorders as well as its relative 
safety in clinical usage. Br J Dermatol 2007; 156:830–7.
Squamous cell carcinoma of the nails
Subungual squamous 
cell carcinoma (SCC) 
is rare. Its diagnosis 
is often missed or 
delayed because the 
clinical presenta-
tion is often atypical, 
and it can mimic 
other conditions such 
as verruca vulgaris, 
o n y c h o m y c o s i s , 
trauma-induced nail dystrophy or exostosis. In this retrospec-
tive study Dalle et al. analysed 35 cases of nail SCC. A wide 
range of clinical features was encountered, including leuco-
nychia, subungual hyperkeratosis, trachonychia, subungual 
tumoral syndrome, longitudinal erythronychia and melanon-
ychia. In many cases the diagnosis was delayed, and most 
cases were invasive at the time of diagnosis. Most often the 
fingernails were affected. On toenails, only the big toe was 
regularly affected. Wide surgical excision led to a lower risk 
of relapse. In cases of more limited surgical treatment (sav-
ing part of the affected nail), micrographic surgery should be 
considered for a better control of the margins. Br J Dermatol 
2007; 156:871–4.
Topical corticosteroids wrongfully 
accused in atopic dermatitis
Sound investigation to determine whether topical corticos-
teroids induce suppression of hypothalamic–pituitary–adre-
nal function is lacking. In this study, basal serum cortisol 
levels of patients with severe atopic dermatitis (AD) (inpa-
tients at admission) were decreased compared with those in 
patients with mild AD (outpatients), while the use of topical 
corticosteroids during the previous 3 months did not dif-
fer between both groups. Furthermore, basal serum corti-
sol levels of the inpatient group increased during treatment 
with potent topical corticosteroids. This suggests that dis-
ease activity, rather than the use of topical corticosteroids, 
is responsible for low basal serum cortisol levels in patients 
with severe AD. Br J Dermatol 2007; 156:979–85.
Two years of experience with 
etanercept in recalcitrant psoriasis
Ahmad and Rogers reviewed the safety and efficacy of 
etanercept in 49 patients with psoriasis recalcitrant to other 
systemic treatments over a 2-year period. Forty-four patients 
had chronic plaque psoriasis, two were suberythrodermic, 
one had palmoplantar pustular psoriasis and two had acro-
dermatitis continua. PASI 75 was achieved in 47% at week 
24 and in 66% at week 48. Etanercept was stopped in 12 
patients in whom clearance was achieved. Rebound did not 
occur. Four remained in remission (mean 13 weeks) while 
eight relapsed; etanercept was reintroduced in these patients 
with renewed efficacy. Unmasking of latent tuberculosis in 
one patient underlines the need for rigorous tuberculosis 
screening. Br J Dermatol 2007; 156:1010–14.
